期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素Ⅱ受体拮抗剂治疗高血压的研究进展 被引量：1

下载PDF
导出
摘要 血管紧张素（AT）受体拮抗剂能够作用于肾素—血管紧张素—醛固酮系统（RAAS）,在对于高血压的治疗上有着重要的作用。它通过调整血管平滑肌细胞、心肌细胞来增加血管阻力和引起左心室肥厚等,现就AT受体拮抗剂与高血压之间的关系进行分析。
作者 刘正生
机构地区 广西梧州市妇幼保健院
出处 《临床合理用药杂志》 2012年第14期168-169,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 血管紧张素Ⅱ受体拮抗剂 高血压病 研究进展
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1Nickenig G,Baumer AT,Grohe C,et al.Estrogen modulates AT1 receptor gene expression in vitro and in vivo.Circulation,1998,97(22):2197-2201.
  • 2Gohlke P,Pees C,Unger T.AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.Hypertension,1998,3(Pt2)1:349-355.
  • 3Carey RM,Wang ZQ,Siragy HM.Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function.Hypertension,2000,35(1Pt2):155-163.
  • 4Fang TC,Huang WC.Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats.Hypertension,1998,32(2):235-242.
  • 5Deb DK,Chen YZ,Zhang ZY,et al.1,25-D ihydroxyvitam in D3 sup-presses high glucose-induced angiotensinogen expression in kidney cells byblocking the NF-B pathway[J].Am J Physiol RenalPhysiol,2009,296(5):F1212-1218.
  • 6Zeeuw D.,Agarwal R,Amdahl M,et al.Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes(VITAL study):a randomised controlled trial[J].Lancet,2010,376 (9752):1543-1551.
  • 7王鲁雁,孙宁玲.血管紧张素Ⅱ受体拮抗剂(ARB)氯沙坦在高血压治疗中的作用及地位[J].中华高血压杂志,2007,15(z1):11-13. 被引量：8
  • 8刘立新,周书明,姚依群.血管紧张素Ⅱ受体拮抗剂临床研究进展[J].实用医学杂志,2008,24(20):3457-3458. 被引量：8

二级参考文献17

  • 1Dahlt~f B, Devereux R B, Kjeldsen S E, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) :a randomised trial against atenolol [J]. Lancet ,2002,359(9311 ) :995-1003.
  • 2Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE) : principal results of a randomized double-blind intervention trial [ J ]. J Hypertens, 2003,21 (5) : 875- 886.
  • 3Julius S, Kjeldsen S E, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial [J]. Lancet, 2004,363 ( 9426 ) : 2022-2031.
  • 4Verma S , Strauss M. Angiotensin receptor blockers and myocardial infarction [J]. BMJ, 2004,329(7477) : 1248-1249.
  • 5Dickstein K, Kjekshus J. OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction:the OPTIMAAL randomised trial. Optimal trial in myocardial infarction with angiotensin Ⅱ antagonist losartan [J].Lancet, 2002,360(9335):752-760.
  • 6Pfeffer M A, McMurray J J, Velazquez E J, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J]. N Engl J Med, 2003,349 (20): 1893-1906.
  • 7Verdecchia P, Angeli F, Gattobigio R, et al. Do angiotensin Ⅱ receptor blockers increase the risk of myocardial infarction [J]? Eur Heart J, 2005, 26(22) :2381-2386.
  • 8McDonald M A, Simpson S H, Ezekowitz J A, et al. Angiotensin receptor blockers and risk of myocardial infarction : systematic review [J ]. BMJ, 2005,331 (7521) : 873.
  • 9Lee V C, Rhew D C, Dylan M, et al. Meta-analysis: angiotensinreceptor blockers in chronic heart failure and high-risk acute myocardial infarction[J]. Ann Intern Med, 2004, 141 (9):693- 704.
  • 10Pitt B, Segal R, Martinez F A, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) [J]. Lancet,1997,349 (9054) : 747-752.

共引文献14

同被引文献8

引证文献1

临床合理用药杂志
2012年 第14期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部